Generally, the age of onset of the illness occurs in the first year after birth. However, disease symptoms can be reduced and may stabilize over a period of years. Later onset clinical features-vasculitic lesions (chilblains) and intracranial vasculitis- warrants the immediate development of therapeutics to treat AGS.